ebook img

Hypertension. January-June 2004: Vol 43 Index PDF

3.9 MB·English
by  
Save to my drive
Quick download
Download
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.

Preview Hypertension. January-June 2004: Vol 43 Index

Volume 43, January-June 2004 Abbey-Hosch SE, 1103 Bean KE, 182 Cain AE, 405 Conlin PR, 393 Abboud FM. 312 Beierwaltes WH, 79 Calhoun DA, 518 Cooper ME, 276 Abe Y, 117, 841 Beilin LJ, 208 Callahan M. 270 Cooper RS, 10, 477, 555 Abraham NG, 1221 Bell TD, 57 Callera GE, 872 Coote JH, 1023 Adamopoulos C, 182 Bella JN, 1182 Calvo C, e22 Cope D, e31 Adeyemo A, 555 Belton NR. 610 Campbell DJ, 169, 854 Corvol P, 854 Adji A. elO Benet M, 249 Campbell WB, 358, 413 Covelo M, e22 Agabiti-Rosei E, 561, 731 Benetos A, 182 Campia U, 36 Cowley AW Jr, 341, 752 Aggarwal A, 169 Bengtsson K, 592 Campo C, 1338 Cramer MJM, el4 Aguilar F, 87 Benigni A, 614 Cao C, 243 Crescenzi A, 317 Ahn HY, 1086 Benjamin EJ, 957, 1239 Cao Z, 276 Crook E, 1202 Aickin M, 393 Benson SC, 993 Capone ML, 64 Cui JS, 586 Aileru AA, 270 Beppu S, 237 Capparelli MF, 623 Cui T-X, 263, 1003 Akino M. 1195 Berenson GS, 541 Cappellini A, 614 Alausa T, 573 Bergman RN, 1324 Cappuccio FP, 598, 1017 Alayash Al, 1110 Bernstein KE. 849, 854 Capra A. elO da Silva A A, 41, 370, 383, 1312 Albermann L, 952 Berr SS, 680 Capron MH. 803 Daftary AR, 1279 Alderman MH, 983 Bertolozzi 1. 101 Cardillo C. 36 Dahly-Vemon AJ, 860 Alemany R, 249 Besnard S, 1270 Carey RM, 286, 680, 943, 1133 Dahlof B, 1029 Alexander BT, 420, 623, 832 Bhattacharyya S, 224 Caron A, 1110 Dai X, 1048 Alexandrov AV, 214 Bishop SP, 680 Carretero OA, 229, 1067, 1140 Dandrea J, 1290 Alexiou T, 854 Bissery A, 785 Carroll MA, 623 Danser AHJ, 488 Alfakih K. 1189 Black HR. 198 Carter BL. 4 Danziger RS, 282 Allen JC. 1153 Blake KV, 208 Carvalho MHC, 872 Daviglus ML, 1332 Almasy L. 780 Blanco CE, 1283 Cassell MD, 1116 Davisson RL, 312 Anderson WP, 643 Blangero J, 780, 1146 Cassis P, 614 de Andrade M, 483 Angeli F, 963 Bluyssen HAR. 947 Castellano M, 561, 731 De Ceglia S, elO Antwi S, 1017 Boari GEM. 561 Castiglioni P, e32 De Ciuceis C, 399, 561 Appel LJ. 393 Bocchi B, 803 Cattaruzza M, 726 de Faire U, el8 Aquilani S, 814 Boddi M, 101 Cavasin MA, 1140 de Jong PE, 791 Arikawa E, 667 Boden-Albala B, 775 Cecioni I, 101 de Leeuw PW, 1283 Arima H, 536 Boehmer C, 1175 Cerudelli B, 561 De Lima JJG, e20 Arima S, 352 Boerwinkle E. 477. 483 Cerutti C, e32 De Mey JGR, 1283 Arnett DK. 1182 Bolla M. 1264 Chade AR. 493 de Paula FJ, e20 Arosio E. 64 Bonadonna S, 561 Chakravarti A, 477 de Paula RB, 41 Asante-Poku S, 1175 Bonazzola S, 614 Challis B, 224 de Simone G, 714 Asanuma H, 237 Bondy B, 1175 Chao J, 109, 452 de Zeeuw D, 791 Asico LD, 654, 673 Bongartz LG, el4 Chao L, 109, 452 Degan M, 64 Athirakul K, 364 Bonvalet JP, 803 Chapleau MW, 312 Dekker JM, 176 Atwood LD, 466 Bonzi B, 731 Chappell MC. 849 Denhardt D, 1195 Austin H, 1246 Booz GW, 1162 Chaves FJ, e7 Dennis BH, 1332 Averill DB, 970 Borecki IB, 780 Chen S, 866 Desai P, 993 Avery MA, 993 Borgioni C. 963 Chen W, 541 Devereux RB, 769, 1029, 1182 Aviv A, 182, 707 Borlongan CV, 452 Cheng H-F, 525 Devost D, 1270 Avolio A, 341 Bouhaddi M. e32 Cheng Y, 629 Di Carlo S, e5 Ayajiki K, 255 Bouter LM, 176 Chillon J-M, 1092 Di Rienzo M, e32 Ayala DE, e22 Bove CM, 680 Chittiboyina A, 993 DiBona GF, 147 Aydin A. 471 Braam B, el4, 947 Cho SI. 1086 Didion SP, 661, 1074 Azizi M, 785, 803 Bracco C, %3 Chobanian AV, e27, e28, e31 Diedrich A, 1035, 1042 Brage S, 224 Chon H, 947 Dietz R, 460 Brambilla R, elO Baamonde C, 249 Brands MW, 57 Chowdhary S, 1023 Di'ez J, 1164 Bader M, 460 Brasen J-H, 911 Christensen H, e36 Diez-Roux AV, 775 Bae YM. 1086 Bray GA, 393 Christman BW, 186 Dijstelbloem HM, 947 Bahring S, 471 Breen JF, 493 Cingolani O, 229, 1067 Dikalov SI, 1246 Bainbridge G, 1189 Brennand J, 224 Ciro A, elO Dina JP, 131 Bakker SJL. 791 Brosnihan KB, 849, 970 Cividjian A, e32 DiPette DJ, 1153 Bakris GL. 573, 941 Brown NJ, 186 Claustrat B, 87 DiTullio MR, 775 Ball DL, 358 Bruemmer D, 297 Claydon VE, 809 Diz DI, 270 Balmforth AJ, 1189 Budge MM, e25 CLUE Study Group Dobrian AD, 48 Banegas JR, 10. 1338 Buijs RM. 192 Investigators, 1338 Dodd J, 643 Barba G, 598 Burattin A, 561 Cody AN, 1103 Doherty D, 208 Barengo NC, 25 Burgerhof JGM, 791 Coelho OR, 1060 Dominguez MJ, e22 Barkley RA, 477 Burke SL, 636 Coffman TM, 364, 445 Doughty RN, 94 Barres C, 629 Burke V, 208 Cohen HW, 983 Dragon DN, 820 Batenburg WW, 488 Busjahn A, 471 Cohen JD, 4 Drazner MH, 1160 Bath PMW, 18, e36 Buttgereit J, 460 Cole SA, 466 du Cailar G, 219 Batlle D, 1120 Coleman HA, 643 Duan X, 578 Battell M, 667 Colucci WS, 957 Dudley A, 1202 Baumbach GL, 1092 Cacho PM, e27 Comuzzie AG, 1146 Duprez D, e3, 936 1355 1356 Author Index Eastwood JB, 1017 Gagov H, 891 Harsha DW, 393 Ito K, 156 Ecker JL, 988 Gaillard CAJM, 947 Hartikainen A-L, 825 Ito S, 352 Edgley AJ, 643 Gainer JV, 186 Hastings J, 169 Iwai M, 263, 1003 Edwards EM, 413 Gaino S, 64 Hayashi K, 603 Iwashima Y, 1318 Egan BM, el2, 358 Galante A, 814 Hayflick JS, 885 Izhar M, 198, 573 Egashira K, 739 Galipeau D, 667 He FJ, el2 Eisenhofer G, 907, 1227 Gallagher PE, 849, 970 He J, 578 Jack CR, 483 Eisner GM, 654, 673 Galligan JJ, 329, 1048 Head GA, 636 James R, 1146 Ekelund U, 224 Galloway JM, 769 Hecker M, 726 Jamieson N, el7 Eldadah BA, 1227 Gamble GD, 94 Heine RJ, 176 Jankowski J, 1055 Elghozi J-L, e32 Gans ROB, 791 Henrion D, 1264 Jankowski V, 1055 Elijovich F, 388 Ganten D, 270 Henry RMA, 176 Janssen BJA, e32 Elliott P, 825, 1332 Garami Z, 214 Hermida RC, e22 Janssen GMJ, 1283 Ellison RC, 477 Garcia K, 214 Herrera-Acosta J, 722 Jarvelin M-R, 825 Elmarakby A A, 1080 Garcia-Robles R, 1338 Herrman J, 493 Jeck N, 1175 Elton RA, 610 Gardner DG, 866 Herzog CA, e20 Jensen BL, e30 Emmett L, 1017 Gardner DS, 1290 Hesse C, 471 Jem S, 1029 Endemann DH, 399, 1252 Gardner JP, 182 Higashi Y, 1297 Jia N, 1195 Epstein FH, 680 Garrelds IM, 488 Hillebrand U, 952 Jin X-H, 1133 Ernst ME, 4 Gattobigio R, 963 Hillege HL, 791 Jinagouda S, 1324 Escribd PV, 249 Gauthier KM, 413 Hingtgen SD, 312 Jinno T, 263 Esler MD, 169 Geenen DL, 282 Hirata Y, 1214 Joffres MR, 10 Espinosa O, e7 Gensini GF, 101 Hirooka Y, 156 Johnson RJ, 722 European Society of Gentile G, elO Hirose F, 1098 Joles JA, 699, 947 Hypertension Working Group Gcntils M, 1110 Hixson JE, 466 Jones DW, 1, 932 on Blood Pressure and Heart Georgiades A, el8 Hiyoshi H, 1258 Jordan J, 471, 1035, 1042 Rate Variability, e32 German Study Group for Ho Cl, 993 Jose PA, 654, 673 Evans JC, 957 Pediatric Hypertension, 547 Hoagland KM, 860 Jousilahti P, 25 Giampaoli S, 10 Hollenberg NK, 707 Julien C, 629, e32 Faccini G, 64 Giannattasio C, elO Holmes C, 1227 Jung JY, 1086 Gibson B, 57 Holstege FCP, 947 Fahmi S, 1324 Gildea JJ, 286, 1133 Homma S, 775 Failla M, elO Kagami S, 841 Gilson WD, 680 Honda M, 603 Falkner B, 203 Kagiyama S, 977 Girard A, e32 Honda Y, 1098 Faraci FM, 661, 1074 Kai H, 739, 499 Gissler M, 825 Hooper JJ, el8 Farjah M, 282 Kaibuchi K, 156 Giustina A, 561 Hooper PL, el8 Farman N, 803 Kaimoto T, 1208 Gokee A, 1011 Hopfer U, 654 Fazzi GE, 1283 Kammerer CM, 466 Goldstein DS, 907, 1227 Hopkins PN, 1182 Felder RA, 286, 654, 673, 1133 Karemaker JM, e32 Goldstein LB, 137 Hopper JL, 586 Feres T, 131 Kammanchi SA, 988 Gollasch M, 471 Hori M, 237, 686 Femdndez JR, e22 Kashiwagi A, 255 Gong W, 347 Horiuchi M, 263, 1003 Ferrario CM, 270, 970 Katovich MJ, 324, 1233 Goodfriend TL, 358, 518 Howard BV, 769 Fesler P, 219 Katsuta H, 1098 Gosling RG, e25 Howard G, 1324 Fesiis G, 471 Katsuya T, 1318 Gossard F, 1270 Hsueh WA, 297 Fields LE, e28 Kawamoto H, 880, 1208 Gouin N, 466 Hu G, 25 Fiet J, 803 Kawano Y, 536 Graham MF, 837 Huentelman MJ, 1233 Filippucci L, 963 Kaye DM, 169 Granger DN, 924 Hulman S, 203 Fink B, 1246 Kemp BE, 1080 Granger JP, 623, 832 Hum D, 1270 Fink GD, 329, 1048 Kemp R, 347 Grass! G, 154 Hung E, 573 Flack JM, 1202 Kendall GE, 208 Greer lA, el7 Hunt SC, 477, 780 Flasch AK, 860 Kenouch S, 803 Griendling KK, 1246 Flynn JA, 907 Kerry SM, 1017 Gross KW, 1116 Fogo AB, 445 lacone R, 598 Keyes MJ, 1239 Gross V, 1042 Folker A, 573 lacoviello L, 598 Khalil RA, 405, 420, 434, 897 Gu D, 578 Fomage M, 483 lanhez LE, e20 Khraibi AA, 48 Gunaruwan P, el Fomasiero A, 64 lantomo M, 36 Khullar M, e7 Giingar N, 1055 Forrester T, 555 lellamo F, 814, e32 Kieval RS, 306 Guo D, 1332 Fortepiani LA, 918 Iglarz M, 1252 KiharaS, 1318 Gupta VK, e29 Fortes ZB, 872 lida M, 977 Kim B, 1086 Fortrat J-O, e32 Ikenoue N, el7 Kim J, 1086 Frampton C, 94 Habib A, 1264 Imaizumi T, 499,739 Kim SH, 243 Franchini KG, 1060 Hadtstein C, 547 Imig JD, 533 Kim SM, 243 Francois H, 364 Haefeli WE, 471 Inomata N, 880 Kimura S, 117, 841 Franks PW, 224 HaffnerSM, 1324 Inoue T, 880 Kimura Y, 156 French BA, 680 Hailpem SM, 983 InterASIA Collaborative Group, Kiryu J, 1098 Frenneaux MP, el, e5 Hainsworth R, 809 578 Kishi T, 156 Friedrich B, 1175 Hall AS, 1189 INTERMAP Research Group, Kissebah AH, 1146 Fries RS, 1301 Hall JE, 1, 41, 370, 383, 1312 1332 Kitabatake A, 1195 FrostegSrd J, el8 Hall LD, 186 Iradi A, e7 Kitakaze M, 237 Fu Y, 1318 Hamet P, 1270 Irving RJ, 610 Kitzman DW, 1182 Fuchs S, 854 Han JH, 243 Irwin ED, 306 Kiyomoto H, 841 Fuji! K, 977 Haque MZ, 335 Ishibashi S, 1214 Kizer JR, 1182 Fukaya T, el7 Harrap SB, 586 Ishikawa K, 1318 Knepper MA, 860 Fukuhara M, 977 Harris RC, 525 Ishikura F, 237 Knot HJ, 1233 Fukuo K, 880, 1208 Harris S, 186 Ishiyama Y, 970 Kobori H, 1126 Funahashi T, 1318 Harrison DG, 1246 Ishizaka N, 1214 Koga M, 499 Author Index 1357 Kohagura K, 352 Lindblad U, 592 McNair LL, 897 Nissinen A, 25 Kohno M, 841 Lindsay C, 71 McNeill JH, 667 Nithipatikom K, 358 Kon S, 1195 Lionetti M, e5 Melander O, 592 Nocco M, e5 Kondo S, 841 Lipman RD, e24, e34 Menard J, 785 Node K, 237 Koomans HA, 699, 947 Liu H-W, 263 Menu P, 1110 Norgiolini S, 963 Kopin U, 1227 Liu JE, 1182 Metcalfe BL, 1233 Noris M, 614 Kostense PJ, 176 Liu K, 1332 Micah FB, 1017 North KE, 780 Kraaijenhagen RJ, 947 Liu L, 1195 Michelini LC, 317 Northcott CA, 125, 885, e29 Kramer CM, 680 Liu R, 649 Middelberg RPS, 224 Kramer GL, 849 Liu Y-H, 229, 1067 Mikhail N, e31 Obarzanek E, 393 Kramer H, 10, 555 Llinas MT, 623, 832 Miller ER III, 393 Oberleithner H, 952 Kreulen DL, 1048 Lo M, 87 Miller MB, 780 Oberman A, 780, 1182 Krieger EM, e20 Logan E, 270 Mimran A, 219 Obst M, 1042 Krien U, 891 Lohmeier TE, 306 Min L-J, 1003 O’Connor DT, 1301 Krier JD, 493 Lokhandwala M, 376 Minamino T, 237 Ogihara T, 263, 880, 1208, 1318 Krozowski Z, 169 London MG, 163 Minuz P, 64 Ogita H, 237 Kruckeberg WC, 832 Long DA, 722 Mitchell GF, 151, 1239 Ohama K, 1297 Kubota E, 603 L6pez JE, e22 Miwa T, 686 Ohashi K, 1318 Kudo H, 499 Lopez LV, 797 Miwa Y, 536 Ohishi M, 1318 Kuo JJ, 370, 383, 1312 L6pez-Rodriguez I, e22 Miyahara S, 1098 Ohmit SE, 1202 Kurtz TW, 993 Loufrani L, 1264 Miyamoto K, 1098 Ohtani T, 686 Kushner H, 203 Lovallo WR, 760 Miyata K. 841 Ohtsuka M, 1297 Kuwahara F, 499, 739 Luan J, 224 Modesti PA, 101 Oikarinen L, 1029 Kwon SC, 1086 Ludwig T, 952 Modrall JG, 849 Okamoto H, 1195, 1258 Luff SE, 643 Moehle R. 1175 Okamura T, 255 Labat C, 182 LuftFC, 471,911, 1035, 1042, Mogi M, 1208 Okin PM, 769. 1029 Labrude P, 1110 1155 Mois6 A, e5 Okumura M, 1003 Laffer CL, 388 Luke A, 555 Mojon A, e22 Oliverio MI, 445 Lagosta VJ, 1060 Lukoshkova E, e32 Mokwe E, 1202 Onozuka H, 1195 Laitinen J, 825 Lum C, 79 Montague C, 224 O’Rahilly S, 224 Lakka TA, 25 Lumachi C, 101 Montano N, e24 O’Rourke MF, elO, e25 Lamarre-Cliche M, 785, 803 Luo J, 1055 Monteduro C, 731 Orshal JM, 434 Lambert E, 169 Luque M, 1338 Montezano AC, 872 Osuga J-i, 1214 Lambert G, 169 Moreno H Jr, 1060 Ouchi N, 1318 Lamon BD, 347 Ma X, 312 Mori T, 752, 341 Ozawa Y, 1126 Morimoto J, 1195 Lampert A, 1175 MacCluer JW, 466 Morineau G, 803 Landau LI, 208 Macconi D, 614 Pacak K, 907, 1227 Morris BJ, 766 Ung F, 1175 MacGregor GA, el2 Pagani M, e32 Mosley TH, 483 Lang PA, 1175 Mahapatra NR, 1301 Pagel I, 460 Motone M, 1318 Lang UE, 1175 Mahata SK, 1301 Paini A, 731 Moutquin J-M, 71 Langenickel T, 460 Mahboubi P, 1301 Paiva ACM, 131 Muffat-Joly M, 803 Laniado-Schwartzman M, 388, Mairuhu G, 192 Paiva TB, 131 Muhl A, 471 1221 Majid DSA, 335 Pankow JS, 780 Muiesan ML, 561, 731 LaPointe MS, 1120 Malave H, 186 Panza JA, 36 Muntner P, 578 Larson MG, 957, 1239 Malliani A, e24 Paranicas M, 1182 Murabito JM, 957 Lassila M, 276 Mancia G, 154, elO, e32 Parati G, e32 Muszkat M, 31 Lattrich C, 726 Mangoni AA, 531 Parilak LD, 1233 Mutter WP, 988 Laude D, e32 Mano T, 686 Parise H, 1239 Myers MG, 724 Lavoie JL, 1116 Mao L, 364 Park J-C, 1086 Myklebust J, 1146 Le TH, 445 Maqbool A, 1189 Parkington HC, 643 Lechi A, 64 Marchuk DA, 445 Pasta F, 614 Lee ET, 769 Marciani MG, 814 Naaz P, 1120 Patrick TE, 1279 Lee K, 1297 Marigliano V, e5 Nadruz W Jr, 1060 Patrignani P, 64 Legramante JM, 814 Marks J, 1146 Nagai R, 1214 Patrono C, 64 Lehmann G, 891 Marsh AM, 1023 Nagai Y, 841 Payne JA, 405, 420 Leik CE, 837 Martin DS, 214 Nasjletti A, 347, 388, 1221 Pearce D, 866 Lembo G, el5 Martin LJ, 1146 Naso C, e5 Pearce S, 1290 Leonardi-Bee J, 18, e36 Martin-Peprah R, 1017 Nasser SA, 1202 Pema AM, 101 Lerman A, 493 Marwaha A, 376 Navar LG, 1126 Pershadsingh HA, 993 Lerman LO, 493 Massaro M, 814 Ness RB, 1279 Persson AEG, 649 Ldvesque S, 71 Masuyama T, 686 Neuenfeld Y, 471 Persson PB, e32 Levine RJ, 988 Materson BJ, 1166 Neumann J, 1055 Petnehazy T, 924 Levy BI, 1264 Mathur S, 661, 1074 Neves MF, 399 Pfister SL, 428 Levy D, 957, 1239 Matsubara H, 680 Newnham JP, 208 Phillips MI, 746 Levy-Toledano S, 1264 Matsuda H, 603 Nieminen MS, 1029 Phillips RO, 1017 Li H-S, 1003 Matsui Y, 1195 Nightingale AK, e5 Piao FL, 243 Li J-M, 263, 1003 Matsumura K, 977 Nigro D, 872 Picciolo C, 614 Li JY, 87 Matsuo A, 1318 Nijpels G, 176 Piccirillo G, e5 Li S, 541 Matsuzawa Y, 1318 Nishijima K, 1098 Pilowsky PM, 945 Li Z, 263 Maucci R, 614 Nishikawa N, 686 Pilz B, 911 Liao JK, 1171 McCarthy MI, 825 Nishimatsu H, 1214 Placidi F, 814 Liao Y, 237 McCormick JA, 866 Nishio 1, el5 Plange-Rhule J, 1017 LIFE Study Investigators, 1029 McGrath HE, 1133 Nishio M, 686 Plante GE, 163 Lin P-H, 393 McKey BS, 760 Nishio Y, 255 Plehm R, 1042 Lin Y, 977 McKinley MJ, 854 Nishiyama A, 117, 841 Pockley AG, el8 1358 Author Index Poisa P, 731 Ruiz-Opazo N, 797 Sharpe N, 94 Tang Y, 746 Pollock DM, 1080 Ruokonen A, 825 Shen L, 746 Tang YL, 746 Pollock JS, 1080 Russo O, 598 Sherawat BS, e7 Tanimoto K, 1297 Porcellati C, %3 Russo P, 598 Shesely EG, 79 Tank J, 1035, 1042 Porrati F, 614 Ryan MJ, 661, 1074 Shimokawa H, 156 Tare M, 643 Porteri E, 561 Shinohara K, el7 Tatematsu S, 603 Portman RJ, 214 Shinozaki K, 255 Taylor DG, 1233 Saad MF, 1324 Potter DL, 79 Shiuchi T, 1003 Taylor JA, e24, e34 Sabbaga E, e20 Potter LR, 1103 Shokoji T, 117, 841 Temmar M, 182 Sacco RL, 775 Poulter N, 10 Shore AC, 610 Ter6s S, 249 Sacks FM, 393 Pouta A, 825 Siani A, 598 Thadhani R, 988 Sadjadi J, 849 Powers RW, 1279 Siedler H, 471 Thamm M, 10 Saez GT, e7 Prabaker K, 866 Sigmund CD, 312, 661, 1074, Thomas F, 182 Saez JM, 87 Pravenec M, 993 1116 Thulin T, el8 Safar ME, 163, 341 Pretorius M, 186 Singer GM, 198 Tian X, 312 Sakata Y, 686 PREVEND Study Group. 791 Siragy HM, 286, 1133 Todeschini M, 614 Salabat MR, 1120 Prewitt RL, 48 Sivananthan M, 1189 Toivonen L, 1029 Salamanca DA, 897 Price KL, 722 Sk0tt O, e30 Toka HR, 471 Salvetti M, 731 Prickett TCR, 94 Salzler HR, 445 Skurk C, 1168 Toka 0,471 Prieto-Carrasquero MC, 1126 Sleiman I, 561 Tokuda K, 499, 739 Sam F, 957 Primatesta P, 10 Smimakis KV, 988 Tokuyama H, 603 Samollow PB, 466 Province MA, 477, 1182 Soergel M, 547 Tombini M, 814 Sanada M, 1297 Pu Q, 399 Sofowora GG, 31 Tommasoli R, 64 Sanada S, 237 Song D, 667 Tonkiss J, 797 Sanchez R, 1270 Qi N, 993 Sanders MW, 1283 Sonnenberg GE, 1146 Tormos MC, e7 Qian K, 746 Sanders PW, 142 Sorof JM, 214 Tostes RC. 872 Quan S, 1221 Sangaleti CT, 317 Sovio U, 825 Toussaint-Hacquard M, 1110 Quintin L, e32 Santonastaso CL, 64 Sowers JR, 941 Touyz RM, 399, 872, 1252 Sparks H, 1153 Townend JN, 1023 Santos EAd, 860 Rahman M, 117 Saruta T, 603 Speirs HJL, 766 Tremblay J, 1270 Raizada MK, 324, 1233 Sasaguri T, 536 Spitzbarth N, 413 Trivedi M, 376 Rakugi H, 263, 1318 Sasaki S, 286 Srinivasan SR, 541 Tsubakimoto M, 1208 Ramires JA, e20 Sassard J, 87 Stamler J, 1332 Tsuda K. el5 Ramsay MM, 1290 Sasser JM, 1080 Stanley FJ, 208 Tsuda M, 1297 Ramsey J, el7 Sata M, 1214 Stec DE, 720 Tsushima M, 536 Rao DC, 1182 Satoh F, 352 Stegmayr B, 10 Tuomilehto J, 25 Rao S, 1246 Sattar N, e 17 Stehouwer CDA, 176 Turner J, 214 Rustam L, 592 Saul PJ, e32 Stein CM, 31 Turner ST, 477, 483 Rauch A, 471 Saunders E, 1202 Stephenson T, 1290 Reaves PY, 324 Savage PJ, 1324 Stoltz JF, 1110 Uede T, 1195 Reboldi G, 963 Savoia C, 399, 1252 Strazzullo P, 598 Ueshima H, 1332 Reckelhoff JF, 405, 918 Saxena PR, 488 Stuveling EM, 791 Uhrenholt TR, e30 Redon J, e7 Schaefer F, 547 Suei Y, 1297 Ulfig N, 891 Regnard J, e32 Schaeffeler E, 1175 Sugawara A, 352 Uruno A, 352 Relan V, e7 Schafer C, 952 Sugaya T, 255 Remuzzi G, 614 Scheer FAJL, 192 Sugimoto K, 1318 van der Meijden BB, 947 Rewers M, 1324 Schiemann D, 891 Suhara T, 880, 1208 van Dijk RAJM, 176 Rhaleb N-E, 229, 1067, 1140 Schiffrin EL, 399, 872, 938, Sukhatme VP, 988 van Kats JP, 488 Ribstein J, 219 1252 Sullivan JC, 1080 van Leenen D, 947 Richards M, 94 Schillers H, 952 Summar ML, 186 Van Montfrans GA, 192 Ridgway J, 1189 Schlaich MP, 169 Sumners C, 1233 van Someren EJW, 192 Riethmiiller C, 952 Schliiter H, 1055 Sundstrom J, 957 VandeBerg JF, 466 RislerT, 1175 Schmid-Schoenbein GW, 1301 Sung BH, 760 Vanni S, 101 Rittling SR, 1195 Schmidt BMW, e2, e30 Svetkey LP, 393 Vara-Gonzalez LA, e27 Rizzoni D, 561, 731 Schmieder RE, e2, e30 Symonds ME, 1290 Vasan RS, 957, 1239 Roberts JM, 1279 Schmitt M, el, e5 Szczech E, 1035 Vaughan DE, 186 Roccella EJ, e27, e28, e31 Schmitz W, 1055 Vecchione C, el5 Rocchini AP, 1011 Schneider W, 911 Tacconelli S, 64 Veh RW, 891 Rochon G, 1110 Schork NJ, 1301 Taguchi A, 1297 Venezia A, 598 Rockman H, 364 Schram MT, 176 Tahara N, 499 Verdecchia P, 963 Rodriguez CJ, 775 Schriver SD, 48 Takamatsu I, 603 Vettorello M, e32 Rodriguez F, 347 Schroeder C, 471 Takano M, 1258 Vieira MLC, e20 Rodriguez-Artalejo F, 1338 Schubert R, 891 Takashima S, 237 Viitasalo M, 1029 Rodriguez-Ledo MP, e22 Schwab M, 1175 Takemiya K, 499 Villanueva M, 1067 Rodriguez-Porcel M, 493 Schwarz JR, 891 Takemura Y, 880, 1208 Vincent AS, 760 Roman MJ, 769 Sciacca RR, 775 Takeshita A, 156, 739 Vincenti A, elO Roman RJ, 860, 1173 Segura J, 1338 Takeuchi K, 352 Vinogradova T, 445 Romigi A, 814 Sehgal AR, 566 Takeya M, 739 Viola S, 731 Rose KM, 780 Selby J, 1324 Talamini G, 64 Virdis A, 399 Rossing MA, 306 Serdar DJ, 306 Tallam LS, 370, 383 Vita JA, 1239 Rousseau F, 71 Seta F, 64 Tallant EA, 970 Vogler O, 249 Roxas BP, 282 Seward JB, e25 Talman WT, 820 von Wowem F, 592 Roy M-C, 71 Seyberth H, 1175 Tamargo J, 1338 Vowinkel T, 924 Ruediger JH, e32 Shaft T, 1202 Tamura H, 1098 Ruilope LM, 1338 Shahin V, 952 Tanaka K, 1214 Wakatsuki A, el7 Author Index 1359 Wakino S, 603 Wesseling KH, e32 Wyche KE, 1246 Yasukawa H, 499 Waldegger P, 1175 Westerhof N, 176 Wynne FL, 405 Yayama K, 1258 Waldegger S, 1175 Whelton PK, 578 Wysocki J, 1120 Ye M,1120 Walker BR, 610 White WB, e3 Yin H. 109, 452 Walker R, 1290 Whitsett TL, 760 Xia C-F, 452 Yokoi T, 880, 1208 Walsh K, 1168 Wilcox CS, 654, 673 Xiao HD, 854 Yoshida J, 686 Walsh SW, 837 Willenbrock R, 460 Xiaobin L, 182 Yoshizumi Masanori, 841 Walters K, 1189 Willey A, 837 Xu H, 329 Wan F, 214 Willmot M, 18 Xu H-L, 352 Yoshizumi Masao, 1297 Wand G, 907 Willnot M, e36 Xu J, 229 You D, 1264 Wang D, 654, 673 Wilson MF, 760 Yu C-h, 849 Wang Jiaming, 993 Wilson PWF, 957 Yamamoto Kazuhiro, 686 Wang Jian, 866 Wissinger B, 1175 Yamamoto Kouichi, 1318 Zaccaro D, 1324 Wang SS, 1246 Witte K, 547 Yamamoto T, 499 Zafari AM, 1246 Wang Z, 673 Wolf G, 693 Yan LL, 1332 Zeng C, 654, 673 Wareham NJ, 224 Wolf M, 988 Yandle TG, 94 Zhang G-X, 117 Washington TL, 282 Wolf-Maier K, 10 Yang JQ, 1011 Zhang X, 276 Watanabe K, el7 Wong ZYH, 586 Yang F, 229 Watts SW, 125, 885, e29, 1048 Wood AJJ, 31 Yang H, 324 Zhang YC, 746 Webb DJ, 610 Worthy K, 643 Yang J, 1332 Zhao L, 1332 Weber KT, 716 Wright SP, 94 Yang L, 1221 Zhou B, 1332 Weder A, 477, 707 Wu L, 1003 Yang X-P, 229, 1067, 1140 Zhu L, 1332 Weisberg A, 186 Wu X, 578 Yang Zequan, 680 Zidek W, 1055 Welch WJ, 654, 673 Wu Y, 1332 Yang Zhiwei, 673 Zill P, 1175 Wenqi G, 578 Wuhl E, 547 Yao L, 841 Zom TMT, 872 Wenzel UO, 693 Wulfsen I, 891 Yasuda O, 880, 1208 Zureik M, 182 - Subject Index Volume 43, January-June 2004 A Calcium Channel Blocker Azelnidipine Enhances Vascular Protective ACE inhibitors Effects of AT| Receptor Blocker Olmesartan, 263 Determinants of Blood Pressure Response to Quinapril in Black and Cardiovascular and Renal Phenotype in Mice With One or Two Renin White Hypertensive Patients: The Quinapril Titration Interval Genes, 79 Management Evaluation Trial, 1202 Decrease in Hypiothalamic Gamma Adducin in Rat Models of Hyjier- Acetylcholine tension, 324 Angiotensin ll-Induced Vascular Dysfunction Is Mediated by the ATia Dietary NaCl Regulates Renal Aminopeptidase N: Relevance to Receptor in Mice, 1074 Hypertension in the Dahl Rat, 282 Nitric Oxide and Cardiac Muscarinic Control in Humans, 1023 Nitric Oxide Mediates Benefits of Angiotensin II Type 2 Receptor Adolescence Overexpression During Post-Infarct Remodeling, 680 Effect of Birth Weight on Blood Pressure and Body Size in Early Peroxisome Proliferator-Activated Receptor y: implications for Car¬ Adolescence, 203 diovascular Disease, 297 Normative Values for Circadian and Ultradian Cardiovascular PPARy Agonist Rosiglitazone Improves Vascular Function and Low¬ Rhythms in Childhood, 547 ers Blood Pressure in Hypertensive Transgenic Mice, 661 Adrenal gland Retinal Expression of Vascular Endothelial Growth Factor Is Mediated Epoxy-Keto Derivative of Linoleic Acid Stimulates Aldosterone by Angiotensin Type 1 and Type 2 Receptors, 276 Secretion, 358 Upregulation of Angiotensin-Converting Enzyme 2 After Myocardial Hypersensitivity of the Adrenal Cortex to Trophic and Secretory Infarction by Blockade of Angiotensin II Receptors, 970 Effects of Angiotensin II in Lyon Genetically-Hypertensive Rats, Angiotensin antagonist 87 Evidence for a Causal Role of the Renin-Angiotensin System in Neuroendocrine Transcriptome in Genetic Hypertension: Multiple Vascular Dysfunction Associated With Insulin Resistance, 255 Changes in Diverse Adrenal Physiological Systems, 1301 Integrating Drug Pharmacokinetics for Phenotyping Individual Renin Adrenergic Response to Angiotensin II Blockade in Humans, 785 Functional Variant in the «2b Adrenoceptor Gene, a Positional Can¬ Angiotensin I didate on Chromosome 2, Associates With Hypertension, 592 Depletion of Tissue Angiotensin-Converting Enzyme Differentially Adrenergic receptor agonists Influences the Intrarenal and Urinary Expression of Angiotensin Alpha2-Adrenergic Receptor-Induced Vascular Constriction in Blacks Peptides, 849 and Whites, 31 Effect of Reduced Angiotensin-Converting Enzyme Gene Expression ROS During the A.ute Phase of Ang II Hypertension Participates in and Angiotensin-Converting Enzyme Inhibition on Angiotensin Cardiovascular MAPK Activation But Not Vasoconstriction, 117 and Bradykinin Peptide Levels in Mice, 854 Adrenomedullin Angiotensin II Adrenomedullin Protects Against Myocardial Apoptosis After Isch¬ Adjacent Expression of Renin and Angiotensinogen in the Rostral emia/Reperfusion Through Activation of Akt-GSK Signaling, Ventrolateral Medulla Using a Dual-Reporter Transgenic Model, 109 1116 Aging Alterations in Sympathetic Ganglionic Transmission in Response to Changes in Arterial Stiffness and Wave Reflection With Advancing Angiotensin II in (mRen2)27 Transgenic Rats, 270 Age in Healthy Men and Women: The Framingham Heart Study, Angiotensin II Type-1 Receptor Blocker Valsartan Enhances Insulin 1239 Sensitivity in Skeletal Muscles of Diabetic Mice, 1003 Short Telomeres Are Associated With Increased Carotid Atheroscle¬ Assessment of Renal Functional Phenotype in Mice Lacking gp91 rosis in Hypertensive Subjects, 182 Subunit of NAD(P)H Oxidase, 335 Albuminuria ATI Receptor Blocker Added to ACE Inhibitor Provides Benefits at C-Reactive Protein Modifies the Relationship Between Blood Pressure Advanced Stage of Hypertensive Diastolic Heart Failure, 686 and Microalbuminuria, 791 Heterogeneity of Cardiorenal Characteristics in Normotensive Sub¬ AT 1 Receptor Mediated Augmentation of Intrarenal Angiotensinogen in Angiotensin 11-Dependent Hypertension, 1126 jects, 219 Aldosterone Depletion of Tissue Angiotensin-Converting Enzyme Differentially Endothelium-Derived Nitric Oxide Modulates Vascular Action of Influences the Intrarenal and Urinary Expression of Angiotensin Aldosterone in Renal Arteriole, 352 Peptides, 849 Eplerenone Prevents Salt-Induced Vascular Remodeling and Cardiac Different Growth Factor Activation in the Right and Left Ventricles in Fibrosis in Stroke-Prone Spontaneously Hypertensive Rats, 1252 Expierimental Volume Overload, 101 Epoxy-Keto Derivative of Linoleic Acid Stimulates Aldosterone Effect of Reduced Angiotensin-Converting Enzyme Gene Expression Secretion, 358 and Angiotensin-Converting Enzyme Inhibition on Angiotensin Hypersensitivity of the Adrenal Cortex to Trophic and Secretory and Bradykinin Peptide Levels in Mice, 854 Effects of Angiotensin II in Lyon Genetically-Hypertensive Rats, Endogenous Angiotensin and Pressure Modulate Brain Angiotensino¬ 87 gen and ATia mRNA Expression, 317 Impaired 11-^ Hydroxysteroid Dehydrogenase Type 2 Activity in Evidence for a Causal Role of the Renin-Angiotensin System in Sweat Gland Ducts in Human Essential Hypertension, 803 Vascular Dysfunction Associated With Insulin Resistance, 255 Relations of Serum Aldosterone to Cardiac Structure: Gender-Related Heme Oxygenase-1 Gene Expression Modulates Angiotensin II- Differences in the Framingham Heart Study, 957 Induced Increase in Blood Pressure, 1221 Resistant Hypertension, Obesity, Sleep Apnea, and Aldosterone: Identification of Telmisartan as a Unique Angiotensin II Receptor Theory and Therapy, 518 Antagonist With Selective PPARy-Modulating Activity, 993 Role of Osteopontin in Cardiac Fibrosis and Remodeling in Angio¬ Modifier Locus on Mouse Chromosome 3 for Renal Vascular Pathol¬ tensin Il-Induced Cardiac Hypertrophy, 1195 ogy in AT, A Receptor-Deficiency, 445 Angioplasty Modulation of the Inflammatory Response in Cardiovascular Disease, Role of Membrane Potential and Expression of Endothelial Factors in 924 Restenosis After Angioplasty in SHR, 131 Peri-Implantation Undemutrition Programs Blunted Angiotensin II Angiotensin Evoked Baroreflex Responses in Young Adult Sheep, 1290 Angiotensin II Stimulates Calcium and Nitric Oxide Release From Pressure-Independent Effects of Angiotensin II on Hypertensive Myo¬ Macula Densa Cells Through AT| Receptors, 649 cardial Fibrosis, 499 1360 Subject Index 1361 Role for Thromboxane Receptors in Angiotensin-II-Induced Hyper¬ Arginine tension, 364 L-Arginine Attenuates Hypertension in Pregnant Rats With Reduced Role of Pressure in Angiotensin Il-Induced Renal Injury: Chronic Uterine Perfusion Pressure, 832 Servo-Control of Renal Perfusion Pressure in Rats, 752 L-Arginine Depletion in Preeclampsia Orients Nitric Oxide Synthase ROS During the Acute Phase of Ang 11 Hypertension Participates in Toward Oxidant Species, 614 Cardiovascular MAPK Activation But Not Vasoconstriction, 117 Arterial Sympathetic Augmentation in Hypertension: Role of Nerve Firing, Alterations in Sympathetic Ganglionic Transmission in Response to Norepinephrine Reuptake, and Angiotensin Neuromodulation, Angiotensin II in (mRen2)27 Transgenic Rats, 270 169 ETa Receptor Mediates Altered I-eukocyte-Endothelial Cell Interac¬ Angiotensin-converting enzyme tion and Adhesion Molecules Expression in DOCA-Salt Rats, 872 ATI Receptor Blocker Added to ACE Inhibitor Provides Benefits at Arterial pressure Advanced Stage of Hypertensive Diastolic Heart Failure, 686 Blood Pressure Control and Physician Management of Hypertension in Effect of Reduced Angiotensin-Converting Enzyme Gene Expression Hospital Hypertension Units in Spain, 1338 and Angiotensin-Converting Enzyme Inhibition on Angiotensin Decreased Endothelium-Dependent NO-cGMP Vascular Relaxation and Bradykinin Peptide Levels in Mice, 854 and Hypertension in Growth-Restricted Rats on a High-Salt Diet, Increased ACE 2 and Decreased ACE Protein in Renal Tubules From Diabetic Mice: A Renoprotective Combination? 1120 420 Persistent Remodeling of Resistance Arteries in Type 2 Diabetic L-Arginine Attenuates Hypertension in Pregnant Rats With Reduced Patients on Antihypertensive Treatment, 399 Uterine Perfusion Pressure, 832 Prolyl Oligopeptidase Is Involved in Release of the Antifibrotic Prolonged Activation of the Baroreflex Produces Sustained Hypoten¬ Peptide Ac-SDKP, 1140 sion, 306 Role of Endothelium-Derived Hyperpolarizing Factor in ACE Steady-State and Dynamic Responses of Renal Sympathetic Nerve Inhibitor-Induced Renal Vasodilation in Vivo, 603 Activity to Air-Jet Stress in Sinoaortic Denervated Rats, 629 Upregulation of Angiotensin-Converting Enzyme 2 After Myocardial Arteries Infarction by Blockade of Angiotensin II Receptors, 970 Acromegalic Patients Show the Presence of Hypertrophic Remodeling Angiotensinogen of Subcutaneous Small Resistance Arteries, 561 AT| Receptor Mediated Augmentation of Intrarenal Angiotensinogen Arterial Stiffness and Kidney Function, 163 in Angiotensin II-Dependent Hypertension, 1126 Changes in Arterial Stiffness and Wave Reflection With Advancing Cardiovascular and Renal Phenotype in Mice With One or Two Renin Age in Healthy Men and Women: The Framingham Heart Study, Genes, 79 1239 Antihypertensive agents Dopamine D, Receptor Augmentation of D3 Receptor Action in Rat a-2 Adrenergic Transmission and Human Baroreflex Regulation, 1035 Aortic or Mesenteric Vascular Smooth Muscles, 673 Causes and Consequences of Increased Sympathetic Activity in Renal Eplerenone Prevents Salt-Induced Vascular Remodeling and Cardiac Disease, 699 Fibrosis in Stroke-Prone Spontaneously Hypertensive Rats, 1252 Clonidine Improves Spontaneous Baroreflex Sensitivity in Conscious Increased Central Artery Stiffness in Impaired Glucose Metabolism Mice Through Parasympathetic Activation, 1042 and Type 2 Diabetes: The Hoorn Study, 176 Antihypertensive therapy Mediators of Bradykinin-Induced Vasorelaxation in Human Coronary Blood Pressure Management in Patients With Acute Ischemic Stroke, Microarteries, 488 137 Nitric Oxide Donor Sodium Nitroprusside Dilates Rat Small Arteries Determinants of Blood Pressure Response to Quinapril in Black and by Activation of Inward Rectifier Potassium Channels, 891 White Hypertensive Patients: The Quinapril Titration Interval Management Evaluation Trial, 1202 PI3-Kinase Upregulation and Involvement in Spontaneous Tone in Hydrochlorothiazide Versus Chlorthalidone; Evidence Supporting Arteries From DOCA-Salt Rats: Is pi 108 the Culprit? 885 Their Interchangeability, 4 Arterioles Hypertension Treatment and Control in Five European Countries, Endothelium-Derived Nitric Oxide Modulates Vascular Action of Canada, and the United States, 10 Aldosterone in Renal Arteriole, 352 Antioxidants Role of Endothelium-Derived Hyperpolarizing Factor in ACE Long-Term Antioxidant Intervention Improves Myocardial Microvas- Inhibitor-Induced Renal Vasodilation in Vivo, 603 cular Function in Experimental Hypertension, 493 Arteriosclerosis Tempol Lowers Blood Pressure and Sympathetic Nerve Activity But Changes in Arterial Stiffness and Wave Reflection With Advancing Not Vascular O2" in DOCA-Salt Rats, 329 Age in Healthy Men and Women; The Framingham Heart Study, Antiporters 1239 Renal Oxidative Stress in Medullary Thick Ascending Limbs Pro¬ Childhood Blood Pressure as a Predictor of Arterial Stiffness in Young duced by Elevated NaCl and Glucose, 341 Adults; The Bogalusa Heart Study, 541 Aorta Atherosclerosis Changes in Arterial Stiffness and Wave Reflection With Advancing C242T CYBA Polymorphism of the NADPH Oxidase Is Associated Age in Healthy Men and Women: The Framingham Heart Study, With Reduced Respiratory Burst in Human Neutrophils, 1246 1239 Enhanced Vascular Activity of Endogenous Endothelin-1 in Obese Pulse Pressure Is an Independent Predictor for the Progression of Hypertensive Patients, 36 Aortic Wall Calcification in Patients With Controlled Hyperlip¬ Peroxisome Proliferator-Activated Receptor y: Implications for Car¬ idemia, 536 diovascular Disease, 297 Apoptosis Short Telomeres Are Associated With Increased Carotid Atheroscle¬ Adrenomedullin Protects Against Myocardial Apoptosis After Isch¬ rosis in Hypertensive Subjects, 182 emia/Reperfusion Through Activation of Akt-GSK Signaling, Statins Augment Collateral Growth in Response to Ischemia but They 109 Do Not Promote Cancer and Atherosclerosis, 1214 Angiotensin II and Cell Cycle Regulation, 693 1 Homocysteine Enhances Endothelial Apoptosis via Upregulation of Atrial natriuretic factor j Fas-Mediated Pathways, 1208 Sgkl Mediates Osmotic Induction of NPR-A Gene in Rat Inner Kallikrein Gene Transfer Protects Against Ischemic Stroke by Pro- Medullary Collecting Duct Cells, 866 i moting Glial Cell Migration and Inhibiting Apoptosis, 452 Sphingosine-1-Phosphate Inhibits C-Type Natriuretic Peptide Activa¬ I Arachidonic acid tion of Guanylyl Cyclase B (GC-B/NPR-B), 1103 20-HETE and Circulating Insulin in Essential Hypertension With Autonomic nervous system Obesity, 388 Alterations in Sympathetic Ganglionic Transmission in Response to Role of Platelet Microparticles in the Production of Thromboxane by Angiotensin II in (mRen2)27 Transgenic Rats, 270 [ Rabbit Pulmonary Artery, 428 Nitric Oxide and Cardiac Muscarinic Control in Humans, 1023 1362 Subject Index B 2-Hydroxyoleic Acid: A New Hypotensive Molecule, 249 Baroreceptor reflex Hypoadiponectinemia Is an Independent Risk Factor for Hypertension, Transmission of Arterial Baroreflex Signals Depends on Neuronal 1318 Nitric Oxide Synthase, 820 Indicators of Fetal Growth Do Not Independently Predict Blood Baroreflex Pressure in 8-Year-Old Australians: A Prospective Cohort Study, a-2 Adrenergic Transmission and Human Baroreflex Regulation, 1035 208 Baroreflex Buffering of Sympathetic Activation During Sleep: Evi¬ Insulin Resistance and Hypertension: The Insulin Resistance Athero¬ dence From Autonomic Assessment of Sleep Macroarchitecture sclerosis Study, 1324 and Microarchitecture, 814 Integrating Drug Pharmacokinetics for Phenotyping Individual Renin Clonidine Improves Spontaneous Baroreflex Sensitivity in Conscious Response to Angiotensin II Blockade in Humans, 785 Mice Through Parasympathetic Activation, 1042 Low Birth Weight Predicts Higher Blood Pressure But Not Dermal Familial and Genomic Analyses of Postural Changes in Systolic and Capillary Density in Two Populations, 610 Diastolic Blood Pressure, 586 Nitric Oxide May Prevent Hypertension Early in Diabetes by Coun¬ Peri-Implantation Undemutrition Programs Blunted Angiotensin II teracting Renal Actions of Superoxide, 57 Evoked Baroreflex Responses in Young Adult Sheep, 1290 Normative Values for Circadian and Ultradian Cardiovascular Prolonged Activation of the Baroreflex Produces Sustained Hypoten¬ Rhythms in Childhood, 547 sion, 306 Peri-Implantation Undemutrition Programs Blunted Angiotensin II Blacks Evoked Baroreflex Responses in Young Adult Sheep, 1290 Prevalence, Detection, Management, and Control of Hypertension in Positional Identification of Hypertension Susceptibility Genes on Ashanti, West Africa, 1017 Chromosome 2, 477 Urinary Potassium Excretion and Sodium Sensitivity in Blacks, 707 Reduced Endothelial NO-cGMP-Mediated Vascular Relaxation and Blood flow Hypertension in IL-6-lnfused Pregnant Rats, 434 Blood Pressure Management in Patients With Acute Ischemic Stroke, Relationship of Physical Activity and Body Mass Index to the Risk of 137 Hypertension: A Prospective Study in Finland, 25 Blood pressure Renal Interstitial Guanosine Cyclic 3', 5'-Monophosphate Mediates a-2 Adrenergic Transmission and Human Baroreflex Regulation, 1035 Pressure-Natriuresis Via Protein Kinase G, 1133 Activating Mutation of the Renal Epithelial Chloride Channel ClC-Kb Rho/Rho-Kinase Pathway in the Brainstem Contributes to Hyperten¬ Predisposing to Hypertension, 1175 sion Caused by Chronic Nitric Oxide Synthase Inhibition, 156 Adverse Prognostic Significance of New Diabetes in Treated Hyper¬ Role of Adrenergic Activity in Pressor Responses to Chronic Mela- tensive Subjects, 963 nocortin Receptor Activation, 370 Aldosterone Antagonism Attenuates Obesity-Induced Hypertension Role of Hypothalamic Melanocortin 3/4-Receptors in Mediating and Glomerular Hyperfiltration, 41 Chronic Cardiovascular, Renal, and Metabolic Actions of Leptin, Arterial Stiffness and Kidney Function, 163 1312 Association Between Physical Activity and Blood Pressure Is Modi¬ Sympathetic Responses to Stress and Rilmenidine in 2KIC Rabbits: fied by Variants in the G-Protein Coupled Receptor 10, 224 Evidence of Enhanced Nonvascular Effector Mechanism, 636 Baroreflex Buffering of Sympathetic Activation During Sleep: Evi¬ Tempol Lowers Blood Pressure and Sympathetic Nerve Activity But dence From Autonomic Assessment of Sleep Macroarchitecture Not Vascular 0:“ in DOCA-Salt Rats, 329 and Microarchitecture, 814 Two Quantitative Trait Loci Affect ACE Activities in Mexican- Blood Pressure Control and Physician Management of Hypertension in Americans, 466 Hospital Hypertension Units in Spain, 1338 Blood pressure monitoring Blood Pressure Differences Between Northern and Southern Chinese: Daily Nighttime Melatonin Reduces Blood Pressure in Male Patients Role of Dietary Factors: The International Study on Macronutri¬ With Essential Hypiertension, 192 ents and Blood Pressure, 1332 Hypertension Treatment and Control in Five European Countries, Blood Pressure Response to Caffeine Shows Incomplete Tolerance Canada, and the United States, 10 After Short-Term Regular Consumption, 760 Blood pressure response C-Reactive Protein Modifies the Relationship Between Blood Pressure Determinants of Blood Pressure Response to Quinapril in Black and and Microalbuminuria, 791 White Hypertensive Patients: The Quinapril Titration Interval Clonidine Improves Spontaneous Baroreflex Sensitivity in Conscious Management Evaluation Trial, 1202 Mice Through Parasympathetic Activation, 1042 Combination of Renin-Angiotensin System Polymorphisms Is Asso¬ Body mass index ciated With Altered Renal Sodium Handling and Hypertension, Association Between Blood Pressure and Resting Energy Expenditure 598 Independent of Body Size, 555 E>opamine D, Receptor Augmentation of D3 Receptor Action in Rat Evidence for a Gene on Chromosome 13 Influencing Postural Systolic Aortic or Mesenteric Vascular Smooth Muscles, 673 Blood Pressure Change and Body Mass Index, 780 Effect of Birth Weight on Blood Pressure and Body Size in Early Relationship of Physical Activity and Body Mass Index to the Risk of Adolescence, 203 Hypertension: A Prospective Study in Finland, 25 Effect of Dietary Sodium Intake on Blood Lipids: Results From the Body weight DASH-Sodium Trial, 393 Association Between Blood Pressure and Resting Energy Expenditure Endogenous Angiotensin and Pressure Modulate Brain Angiotensino- Independent of Body Size, 555 gen and ATi^ mRNA Expression, 317 Bradykinin Evidence for a Causal Role of the Renin-Angiotensin System in Effect of Reduced Angiotensin-Converting Enzyme Gene Expression Vascular Dysfunction Associated With Insulin Resistance, 255 and Angiotensin-Converting Enzyme Inhibition on Angiotensin Evidence for a Gene on Chromosome 13 Influencing Postural Systolic and Bradykinin Peptide Levels in Mice, 854 Blood Pressure Change and Body Mass Index, 780 Mediators of Bradykinin-Induced Vasorelaxation in Human Coronary Familial and Genomic Analyses of Postural Changes in Systolic and Microarteries, 488 Diastolic Blood Pressure, 586 Relationship Between Carbamoyl-Phosphate Synthetase Genotype and Ghrelin Acts at the Nucleus of the Solitary Tract to Decrease Arterial Systemic Vascular Function, 186 Pressure in Rats, 977 Role of Endothelium-Derived Hyperpolarizing Factor in ACE Guidelines for Hypertension: Are Quality-Assurance Measures on Inhibitor-Induced Renal Vasodilation in Vivo, 603 Target? 198 Stimulation of Cyclic GMP Production via AT2 and B2 Receptors in Heme Oxygenase-1 Gene Expression Modulates Angiotensin II- the Pressure-Overloaded Aorta After Banding, 1258 Induced Increase in Blood Pressure, 1221 Brain Heritability of Leukoaraiosis in Hypertensive Sibships, 483 Decrease in Hypothalamic Gamma Adducin in Rat Models of Hyper¬ High Blood Pressure in Acute Stroke and Subsequent Outcome: A tension, 324 Systematic Review, 18 Heritability of Leukoaraiosis in Hypertensive Sibships, 483 Subject Index 1363 Rho/Rho-Kinase Pathway in the Brainstem Contributes to Hyperten¬ Central nervous system sion Caused by Chronic Nitric Oxide Synthase Inhibition, 156 Blood Pressure Management in Patients With Acute Ischemic Stroke, 137 Cerebrovascular disorders Blood Pressure Management in Patients With Acute Ischemic Stroke, 137 Children Blood Pressure Response to Caffeine Shows Incomplete Tolerance Cardiovascular Risk Factors and Sequelae in Hypertensive Children t After Short-Term Regular Consumption, 760 Identified by Referral Versus School-Based Screening, 214 Calcium Childhood Blood Pressure as a Predictor of Arterial Stiffness in Young Age-Related Reduction in Estrogen Receptor-Mediated Mechanisms Adults: The Bogalusa Heart Study, 541 of Vascular Relaxation in Female Spontaneously Hypertensive Indicators of Fetal Growth Do Not Independently Predict Blood Rats, 405 Pressure in 8-Year-Old Australians: A Prospective Cohort Study, Angiotensin II Stimulates Calcium and Nitric Oxide Release From 208 Macula Densa Cells Through AT| Receptors, 649 Low Birth Weight Predicts Higher Blood Pressure But Not Dermal Attenuation of Lysophosphatidylcholine-lnduced Suppression of ANP Capillary Density in Two Populations, 610 Release From Hypertrophied Atria, 243 Endothelin-1 Promotes Ca"'^ Antagonist-Insensitive Coronary Smooth Normative Values for Circadian and Ultradian Cardiovascular Muscle Contraction Via Activation of e-Protein Kinase C, 897 Rhythms in Childhood, 547 Pulse Pressure Is an Independent Predictor for the Progression of Cholesterol Aortic Wall Calcification in Patients With Controlled Hyperlip¬ Effect of Dietary Sodium Intake on Blood Lipids: Results From the idemia, 536 DASH-Sodium Trial, 393 Calcium channel Statins Augment Collateral Growth in Response to Ischemia but They Calcium Channel Blocker Azelnidipine Enhances Vascular Protective Do Not Promote Cancer and Atherosclerosis, 1214 f Effects of AT| Receptor Blocker Olmesartan, 263 Circadian rhythm I Capillaries Daily Nighttime Melatonin Reduces Blood Pressure in Male Patients \ Low Birth Weight Predicts Higher Blood Pressure But Not Dermal With Essential Hypertension, 192 Capillary Density in Two Populations, 610 Circulation p Carbon monoxide Statins Augment Collateral Growth in Response to Ischemia but They Nitric Oxide Synthesis Inhibition Promotes Renal Production of Do Not Promote Cancer and Atherosclerosis, 1214 { Carbon Monoxide, 347 Clinical trials I Cardiac function Blood Pressure Management in Patients With Acute Ischemic Stroke, Ac-SDKP Reverses Inflammation and Fibrosis in Rats With Heart 137 b Failure After Myocardial Infarction, 229 Dietary Sodium and Blood Pressure, 932 Endogenous Diadenosine Tetraphosphate, Diadenosine Pentaphos- Guidelines for Hypertension: Are Quality-Assurance Measures on phate, and Diadenosine Hexaphosphate in Human Myocardial Target? 198 * Tissue, 1055 Hydrochlorothiazide Versus Chlorthalidone: Evidence Supporting Simvastatin Prevents Load-Induced Protein Tyrosine Nitration in Their Interchangeability, 4 Overloaded Hearts, 1060 Impaired ll-)3 Hydroxysteroid Dehydrogenase Type 2 Activity in Cardiac output Sweat Gland Ducts in Human Essential Hypertension, 803 Aldosterone Antagonism Attenuates Obesity-Induced Hypertension Insulin Resistance and Alterations in Angiogenesis: Additive Insults and Glomerular Hyperfiltration, 41 That May Lead to Preeclampsia, 988 Cardiovascular diseases Manifestations of Metabolic Syndrome After Hypertensive Pregnancy, Blood Pressure Control and Physician Management of Hypertension in 825 Hospital Hypertension Units in Spain, 1338 Collagen C-Reactive Protein Modifies the Relationship Between Blood Pressure Ac-SDKP Reverses Inflammation and Fibrosis in Rats With Heart and Microalbuminuria, 791 Failure After Myocardial Infarction, 229 Cardiovascular Risk Factors and Sequelae in Hypertensive Children Eplerenone Prevents Salt-Induced Vascular Remodeling and Cardiac Identified by Referral Versus School-Based Screening, 214 Fibrosis in Stroke-Prone Spontaneously Hypertensive Rats, 1252 Childhood Blood Pressure as a Predictor of Arterial Stiffness in Young Compliance Adults: The Bogalusa Heart Study, 541 Increased Central Artery Stiffness in Impaired Glucose Metabolism Left Ventricular Concentric Geometry During Treatment Adversely and Type 2 Diabetes: The Hoorn Study, 176 Affects Cardiovascular Prognosis in Hypertensive Patients, 731 Constriction Major Quantitative Trait Locus for Resting Heart Rate Maps to a Decreased Endothelium-Dependent NO-cGMP Vascular Relaxation Region on Chromosome 4, 1146 and Hypertension in Growth-Restricted Rats on a High-Salt Diet, Obesity and Hypertension-Induced Restrictive Cardiomyopathy: A 420 Harbinger of Things to Come, 911 Coronary disease Carotid arteries Glucose-Cholesterol Interaction Magnifies Coronary Heart Disease Angiotensin Il-Induced Vascular Dysfunction Is Mediated by the ATja Risk for Hypertensive Patients, 983 Receptor in Mice, 1074 Corticosterone I PPARy Agonist Rosiglitazone Improves Vascular Function and Low- Hypersensitivity of the Adrenal Cortex to Trophic and Secretory I ers Blood Pressure in Hypertensive Transgenic Mice, 661 Effects of Angiotensin II in Lyon Genetically-Hypertensive Rats, I Role of Membrane Potential and Expression of Endothelial Factors in 87 I Restenosis After Angioplasty in SHR, 131 Impaired 11-^ Hydroxysteroid Dehydrogenase Type 2 Activity in P Short Telomeres Are Associated With Increased Carotid Atheroscle- Sweat Gland Ducts in Human Essential Hypertension, 803 I rosis in Hypertensive Subjects, 182 Cross-sectional studies [ Catecholamines Factors Associated With Hypertension Awareness, Treatment, and Nitric Oxide and Cardiac Muscarinic Control in Humans, 1023 Control in a Representative Sample of the Chinese Population, : Sympathetic Augmentation in Hypertension: Role of Nerve Firing, 578 E Norepinephrine Reuptake, and Angiotensin Neuromodulation, Hypertension Treatment and Control in Five European Countries, i 169 Canada, and the United States, 10 ^ Cell adhesion molecules Cyclic GMP ETa Receptor Mediates Altered Leukocyte-Endothelial Cell Interac¬ Characterization of a cGMP-Response Element in the Guanylyl tion and Adhesion Molecules Expression in DOCA-Salt Rats, 872 Cyclase/Natriuretic Peptide Receptor A Gene Promoter, 1270 In Vivo Evaluation of Retinal Injury After Transient Ischemia in Forced Homodimerization by Site-Directed Mutagenesis Alters Gua¬ Hypertensive Rats, 1098 nylyl Cyclase Activity of Natriuretic Peptide Receptor B, 460 1364 Subject Index Production and Role of Extracellular Guanosine Cyclic 3', 5' Mono¬ Role of Endothelin-1 in Blood Pressure Regulation in a Rat Model of phosphate in Sodium Uptake in Human Proximal Tubule Cells, Visceral Obesity and Hypertension, 383 286 Diuretics Reduced NOS3 Phosphorylation Mediates Reduced NO/cGMP Sig¬ Adverse Prognostic Significance of New Diabetes in Treated Hyper¬ naling in Mesenteric Arteries of Deoxycorticosterone Acetate- tensive Subjects, 963 Salt Hypertensive Rats, 1080 Effects of Indapamide, a Thiazide-Like Diuretic, on Structure of Renal Interstitial Guanosine Cyclic 3', 5'-Monophosphate Mediates Cerebral Arterioles in Hypertensive Rats, 1092 Pressure-Natriuresis Via Protein Kinase G, 1133 Hydrochlorothiazide Versus Chlorthalidone: Evidence Supporting Sphingosine-1-Phosphate Inhibits C-Type Natriuretic Peptide Activa¬ Their Interchangeability, 4 tion of Guanylyl Cyclase B (GC-B/NPR-B), 1103 Dopamine Stimulation of Cyclic GMP Production via AT2 and Bt Receptors in Aberrant D| and Dj Dopamine Receptor Transregulation in Hyperten¬ the Pressure-Overloaded Aorta After Banding, 1258 sion, 654 Cyclooxygenase Dopamine D, Receptor Augmentation of D, Receptor Action in Rat Cyclooxygenase Involvement in Thromboxane-Dependent Contrac¬ Aortic or Mesenteric Vascular Smooth Muscles, 673 tion in Rat Mesenteric Resistance Arteries, 1264 Rosiglitazone Restores G-Protein Coupling, Recruitment, and Func¬ Cyclooxygenases, the Kidney, and Hypertension, 525 tion of Renal Dopamine D|a Receptor in Obese Zucker Rats, 376 Role for Thromboxane Receptors in Angiotensin-II-Induced Hyper¬ Drug therapy tension, 364 Overlap Between Whites and Blacks in Response to Antihypertensive CYP-450 Drugs, 566 Cytochrome P-450 Inhibition Attenuates Hypertension Induced by Reductions in Uterine Perfusion Pressure in Pregnant Rats, 623 E Echocardiography D Adverse Prognostic Significance of New Diabetes in Treated Hyper¬ Deoxycorticosterone tensive Subjects, 963 ETa Receptor Mediates Altered Leukocyte-Endothelial Cell Interac¬ Amino-Terminal Pro-C-Type Natriuretic Peptide in Heart Failure, 94 tion and Adhesion Molecules Expression in DOCA-Salt Rats, 872 Cardiovascular Risk Factors and Sequelae in Hypertensive Children Low [Mg^'^'le Enhances Arterial Spontaneous Tone via Phosphatidyl- Identified by Referral Versus School-Based Screening, 214 inositol 3-Kinase in DOCA-Salt Hypertension, 125 Combined Echocardiographic Left Ventricular Hypertrophy and Elec¬ p38 Mitogen-Activated Protein Kinase Contributes to the Diminished trocardiographic ST Depression Improve Prediction of Mortality Aortic Contraction by Endothelin-1 in DOCA-Salt Hypertensive in American Indians: The Strong Heart Study, 769 Rats, 1086 Raloxifene Prevents Cardiac Hypertrophy and Dysfunction in Reduced NOS3 Phosphorylation Mediates Reduced NO/cGMP Sig¬ Pressure-Overloaded Mice, 237 naling in Mesenteric Arteries of Deoxycorticosterone Acetate- Relations of Serum Aldosterone to Cardiac Structure: Gender-Related Salt Hypertensive Rats, 1080 Differences in the Framingham Heart Study, 957 Diabetes mellitus Editorial Commentaries Angiotensin II Type-I Receptor Blocker Valsartan Enhances Insulin ACE Inhibition and Bradykinin-Mediated Renal Vascular Responses: Sensitivity in Skeletal Muscles of Diabetic Mice, 1003 EDHF Involvement, 533 Guidelines for Hypertension: Are Quality-Assurance Measures on Angiotensin Type-1 Receptor Blockade Increases ACE 2 Expression Target? 198 in the Heart, 943 Increased Central Artery Stiffness in Impaired Glucose Metabolism Cardiac Angiotensin AT2 Receptor: What Exactly Does It Do? 1162 and Type 2 Diabetes: The Hoorn Study, 176 Concentric or Eccentric Hypertrophy: How Clinically Relevant Is the Insulin Resistance and Hypertension: The Insulin Resistance Athero¬ Difference? 714 sclerosis Study, 1324 Death Receptor Induced Apoptosis: A New Mechanism of Nitric Oxide May Prevent Hyptertension Early in Diabetes by Coun¬ Homocysteine-Mediated Endothelial Cell Cytotoxicity, 1168 teracting Renal Actions of Superoxide, 57 Diastolic and Pulse Pressure: The Old and the New? 531 Novel Mechanisms Responsible for Postmenopausal Hypertension, Effect of Caffeine on Blood Pressure Beyond the Laboratory, 724 918 From Inflammation to Fibrosis: A Stiff Stretch of Highway, 716 Peroxisome Proliferator-Activated Receptor y: Implications for Car¬ Gene Therapy and Heme Oxygenase Coming of Age, 1173 diovascular Disease, 297 How Does Angiotensin II Cause Renal Injury? 722 Persistent Remodeling of Resistance Arteries in Type 2 Diabetic Increased Aortic Stiffness: An Unfavorable Cardiorenal Connection, Patients on Antihypertensive Treatment, 399 151 Renal Oxidative Stress in Medullary Thick Ascending Limbs Pro¬ Is the Female Heart More Sensitive to Aldosterone for Early Remod¬ duced by Elevated NaCl and Glucose, 341 eling? 936 Retinal Expression of Vascular Endothelial Growth Factor Is Mediated Left Ventricular Hypertrophy Is More Common in Black than White by Angiotensin Type 1 and Type 2 Receptors, 276 Hypertensives: Is This News? 1160 Diabetic nephropathy The Many Targets of Aldosterone, 938 Causes and Consequences of Increased Sympathetic Activity in Renal Neurogenic Hypertension: Is the Enigma of Its Origin Near the Disease, 699 Solution? 154 Increased ACE 2 and Decreased ACE Protein in Renal Tubules From Neurotransmission in Central Cardiovascular Control: 10 Suggestions Diabetic Mice: A Renoprotective Combination? 1120 for Microinjections, 945 Diastole Profibrotic Effects of Angiotensin II in the Heart: A Matter of ATI Receptor Blocker Added to ACE Inhibitor Provides Benefits at Mediators, 1164 Advanced Stage of Hypertensive Diastolic Heart Failure, 686 Seventh Report of the Joint National Committee on Prevention, Hypertensive Myocardial Fibrosis and Diastolic Dysfunction: Another Detection, Evaluation, and Treatment of High Blood Pressure and Model of Inflammation? 739 Evidence From New Hypertension Trials, 1 Diet Smart Gene Therapy for the Heart, 720 Blood Pressure Differences Between Northern and Southern Chinese: Statin Therapy: Having the Good Without the Bad, 1171 Role of Dietary Factors: The International Study on Macronutri¬ Variability in Response to Antihypertensive Drug Treatment, 1166 ents and Blood Pressure, 1332 When Does New Onset Diabetes Resulting From Antihypertensive Blood Pressure Response to Caffeine Shows Incomplete Tolerance Therapy Increase Cardiovascular Risk, 941 After Short-Term Regular Consumption, 760 Elasticity Dietary Sodium and Blood Pressure, 932 Changes in Arterial Stiffness and Wave Reflection With Advancing Effect of Dietary Sodium Intake on Blood Lipids: Results From the Age in Healthy Men and Women: The Framingham Heart Study, DASH-Sodium Trial, 393 1239

See more

The list of books you might like

Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.